Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
American Depositary Shares, each representing five ordinary shares, nominal value of 0.003 GBP per share · CUSIP: 589492107
Event date: 2025-12-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 683 Capital Management, LLC
Shares: 65,083,815 · Class: 8.18%
- 683 Capital Partners, LP
Shares: 65,083,815 · Class: 8.18%
- Ari Zweiman
Shares: 65,083,815 · Class: 8.18%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001404574-26-000002
- Form type
- SCHEDULE 13G
- Filer
- 683 Capital Management, LLC
- CIK
- CIK 1404574
- Filed
- Jan 06, 2026
- Reporting period
- Dec 29, 2025
- Description
- Schedule 13G beneficial ownership